Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

8.54USD
7 Dec 2018
Change (% chg)

$0.39 (+4.79%)
Prev Close
$8.15
Open
$8.08
Day's High
$8.90
Day's Low
$7.86
Volume
380,743
Avg. Vol
199,909
52-wk High
$22.00
52-wk Low
$6.94

Chart for

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 2.29
Market Cap(Mil.): $713.08
Shares Outstanding(Mil.): 40.29
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.60 -- --
ROI: -29.33 0.28 15.02
ROE: -30.75 0.94 16.60

Earnings vs. Estimates